NEJM reports that DTC spend increased 330% between '96-'05

Share this article:
In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising increased by 330% between 1996 and 2005, while the number of warning and untitled letters issued on ads fell from 142 in 1997 to 21 in 2006.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions